1. Home
  2. IDE vs ORGO Comparison

IDE vs ORGO Comparison

Compare IDE & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

IDE

Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

HOLD

Current Price

$12.03

Market Cap

199.0M

Sector

Finance

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

BUY

Current Price

$1.03

Market Cap

166.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
IDE
ORGO
Founded
2010
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.0M
166.0M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
IDE
ORGO
Price
$12.03
$1.03
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $2.00
AVG Volume (30 Days)
56.7K
★ 622.5K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 8.83%
N/A
EPS Growth
N/A
★ 1600.00
EPS
★ N/A
N/A
Revenue
N/A
★ $564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$37.55
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 17.04
52 Week Low
$11.36
$0.93
52 Week High
$14.30
$7.08

Technical Indicators

Market Signals
Indicator
IDE
ORGO
Relative Strength Index (RSI) 38.03 17.22
Support Level $11.87 N/A
Resistance Level $13.95 $2.69
Average True Range (ATR) 0.20 0.07
MACD 0.02 -0.02
Stochastic Oscillator 26.53 4.89

Price Performance

Historical Comparison
IDE
ORGO

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: